The FDA this week said that Lupin Pharmaceuticals is recalling batches of its Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets. Doctors use the medication to treat hypertension ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Recently, a Facebook user went viral for calling out a pharmacist who refused to dispense an Rx drug, specifically showing ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

AT-II-receptor antagonists include losartan, valsartan, irbesartan, candesartan, eprosartan, telmisartan, and tasosartan. Several clinical trials have demonstrated that AT-II-receptor antagonists ...

A survey of 2673 patients enrolled in seven double blind, placebo-controlled studies of the effectiveness of irbesartan, an angiotensin receptor blocker, found that in the placebo group ...

Ipriflavone can block part of the process that leads to bone loss. Ipriflavone can block part of the process that leads to bone loss. A bone disease that can cause pain (Paget disease). Early ...

Q3 2024 Earnings Call Transcript October 31, 2024 Travere Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...

FILSPARI ® (sparsentan) received full FDA approval as the only non-immunosuppressive treatment that significantly slows kidney function decline in IgAN Type C meeting scheduled with FDA to discuss ...

Good morning, and welcome to the Travere Therapeutics' Third Quarter 2024 Financial Results Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over ...